Brumme, Z., Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Durban, South Africa; Wang, B., Program HIV Outcomes Research, Massachusetts General Hospital, Boston, United States; Nair, K., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Brumme, C., Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Durban, South Africa; De Pierres, C., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Reddy, S., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Julg, B., Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Durban, South Africa, HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Moodley, E., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Thobakgale, C., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Lu, Z., Program HIV Outcomes Research, Massachusetts General Hospital, Boston, United States; Van Der Stok, M., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Bishop, K., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Mncube, Z., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Chonco, F., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Yuki, Y., Cancer and Inflammation Program, Laboratory of Experimental Immunology, National Cancer Institute, Frederick, United States; Frahm, N., Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Durban, South Africa; Brander, C., Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Durban, South Africa; Carrington, M., Cancer and Inflammation Program, Laboratory of Experimental Immunology, National Cancer Institute, Frederick, United States; Freedberg, K., Program HIV Outcomes Research, Massachusetts General Hospital, Boston, United States; Kiepiela, P., HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Goulder, P., Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Durban, South Africa, HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa, Department of Paediatrics, Nuffield Department of Medicine, Oxford, United Kingdom; Walker, B., Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Durban, South Africa, HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa, Howard Hughes Medical Institute, Chevy Chase, MD, United States; Ndung'u, T., Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Durban, South Africa, HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZuluNatal, Durban, South Africa; Losina, E., Program HIV Outcomes Research, Massachusetts General Hospital, Boston, United States, Program in HIV Epidemiology and Outcomes Research, Massachusetts General Hospital, 50 Staniford St., Boston, MA 02114, United States